Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Anika Therapeutics 32 WIGGINS AVENUE BEDFORD MA 01730 USA

www.anika.com Employees: 288 P: 781-457-9000 F: 781-305-9720

Sector:

Medical

Description:

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.

Key Statistics

Overview:

Market Capitalization, $K 136,711
Enterprise Value, $K 81,081
Shares Outstanding, K 14,421
Annual Sales, $ 119,910 K
Annual Net Income, $ -56,390 K
Last Quarter Sales, $ 27,820 K
Last Quarter Net Income, $ -2,330 K
EBIT, $ 13,030 K
EBITDA, $ 21,150 K
60-Month Beta 0.51
% of Insider Shareholders 9.64%
% of Institutional Shareholders 91.53%
Float, K 13,031
% Float 90.36%
Short Interest 443
Short Float 3.07%
Short Volume Ratio 0.19

Growth:

1-Year Return -41.95%
3-Year Return -67.97%
5-Year Return -79.05%
5-Year Revenue Growth 4.62%
5-Year Earnings Growth -122.44%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.04 on 11/05/25
Next Earnings Date 03/11/26
Earnings Per Share ttm -0.92
EPS Growth vs. Prev Qtr 48.48%
EPS Growth vs. Prev Year 61.36%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ANIK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -8.80%
Return-on-Assets % -6.82%
Profit Margin % -47.03%
Debt/Equity 0.00
Price/Sales 1.13
Price/Cash Flow 98.44
Price/Book 0.92
Book Value/Share 10.18
Interest Coverage -0.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar